Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.

Human gene therapy - 20 Sept 2001

Shi W, Arnold G S, Bartlett J S

Abstract excerpt

Recombinant adeno-associated virus (AAV) vectors are of interest in the context of gene therapy because of their ability to mediate efficient transfer and stable expression of therapeutic genes in a wide variety of tissues. However, AAV-mediated gene delivery to specific cell populations is often...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Capsid
Share to Dependovirus
Share to Epitopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Transfer Techniques

Share to Genetic Therapy

Share to Heparin

Share to Progesterone

Share to Transduction, Genetic

Source

Identifiers

PMID: 11560765
DOI: 10.1089/104303401750476212

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-11560765-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.PMID 11560765Read ↗

Dichotomies in Ex Vivo and In Vivo Performance of Receptor-Binding Mutants of Adeno-Associated Virus Vectors.Semantic proximity Read ↗

Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism.Semantic proximity Read ↗

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.Semantic proximity Read ↗

Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis.Semantic proximity Read ↗

Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism.Semantic proximity Read ↗

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.Semantic proximity Read ↗

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapySemantic proximity Read ↗

Attenuation of Heparan Sulfate Proteoglycan Binding Enhances In Vivo Transduction of Human Primary Hepatocytes with AAV2Semantic proximity Read ↗

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.Semantic proximity Read ↗

Altering AAV tropism with mosaic viral capsids.Semantic proximity Read ↗

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids.Semantic proximity Read ↗

Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.